Anna V. Khokhlova

Anna V. Khokhlova

Auto-generated profile, based on publicly available information

Anna V. Khokhlova

N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2021 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
ANA. K. Nosov
A. K. Nosov
SKS. A. Kuleva
S. A. Kuleva
SIS. V. Ivanova
S. V. Ivanova
ESE. M. Senchurov
E. M. Senchurov
RKR. I. Khabarova
R. I. Khabarova
AKA. V. Khokhlova
A. V. Khokhlova
The modern Wilms tumor treatment protocols used all over the world can cure up to 90 % of children. Such successes make it possible to actively introduce risk-adapted therapy methods aimed at de-escalating the chemotherapy regimen and radiation therapy impact to the tumor. The most conservative was the stage of surgical treatment, implying the organ-depleting nature of the surgery. Nevertheless, over the past decade, a lot of experience has been accumulated with both nephron-sparing and minimally invasive interventions in patients with both bilateral and unilateral Wilms tumor.We presented the experience of laparoscopic kidney resection with intraoperative ultrasound control in a child with unilateral Wilms tumor, receiving treatment at the N.N. Petrov National Medical Research Center of Oncology.

25 September 2019 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
EME. A. Mikhailova
E. A. Mikhailova
SKS. A. Kuleva
S. A. Kuleva
SIS. V. Ivanova
S. V. Ivanova
EGE. D. Gumbatova
E. D. Gumbatova
AAA. S. Artemyeva
A. S. Artemyeva
AKA. B. Kosichkina
A. B. Kosichkina
Over the past two decades, mucormycosis has firmly taken 3rd place among invasive mycoses after candidiasis and aspergillosis in patients with oncohematological diseases. The article presents a clinical case of disseminated mucormycosis that developed in a child with nonHodgkin’s lymphoma on the background of deep immunosuppression.

30 April 2026 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
DSDmitry S. Sudakov
Dmitry S. Sudakov
EKEkaterina A. Kolesnikova
Ekaterina A. Kolesnikova
AKAnna V. Khokhlova
Anna V. Khokhlova
YDYulia R. Dymarskaya
Yulia R. Dymarskaya
EKEkaterina N. Kolomina
Ekaterina N. Kolomina
IBIgor V. Berlev
Igor V. Berlev
The greater vestibular glands of the vagina were described in the 17th century by the Danish anatomist Caspar Bartholin the Younger. In his honor, the glands received their second name — Bartholin’s glands (BG). Obstetricians and gynecologists more often encounter retention and inflammatory lesions of the BG in their routine clinical practice. Furthermore, different types of BG epithelium can be a source of malignant tumors characterized by varying clinical courses. The following malignant BG tumors have been described in the literature: transitional cell carcinoma, neuroendocrine carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma, leiomyosarcoma, and epithelial-myoepithelial carcinoma. The diagnostic criteria for primary BG carcinoma were proposed in 1972 by Dikran L. Chamlian and Herbert B. Taylor and remain valid today: the tumor is located in the BG region and originates from cellular elements characteristic of the region; areas of clear transition from normal vulvar tissue to tumor elements are identified; there are no signs that the tumor is a metastasis from a primary tumor in another location. Malignant vulvar tumors, according to available literature, account for 3% to 5% of all vulvar carcinomas. Despite the rarity of malignant BG diseases, they constitute the majority of vulvar adenocarcinomas. Data on malignant BG tumors in the literature are presented very sparingly, mainly in the form of case reports or small series. This article describes four clinical cases of primary malignant BG tumors. All four patients were treated in the Department of Gynecologic Oncology, the N.N. Petrov National Medical Research Center of Oncology from 2019 to 2025. Two cases of HPV-associated squamous cell carcinoma, one of adenocarcinoma, and one of myoepithelial adenocarcinoma are reported. The authors present the signs and symptoms, clinical course, treatment outcomes, and recurrences of the malignant BG tumors with varying histopathologies. Malignant BG tumors can be cured with a high probability in case of early diagnosis and adequate combined treatment, including surgical removal of the tumor, radiation therapy, and polychemotherapy.